BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, we find the antimalarial artesunate (ART) significantly inhibits USP7/BCR-ABL interaction, thereby promoting BCR-ABL degradation and inducing CML cell death.